4//SEC Filing
Shiferman Gregory L. 4
Accession 0001562180-25-003111
CIK 0001597553other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:09 PM ET
Size
8.4 KB
Accession
0001562180-25-003111
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Award
Common Stock
2025-04-10+525→ 31,205 total - Tax Payment
Common Stock
2025-04-10$6.91/sh−176$1,216→ 31,029 total
Footnotes (1)
- [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 1,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 525 shares.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0002041689
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:09 PM ET
- Size
- 8.4 KB